COST EFFECTIVENESS MODEL ON FOUR PREVENTIVE TREATMENT FOR CLOSTRIDIOIDES DIFFICILE INFECTION RECURRENCE FROM A US PAYER PERSPECTIVE

被引：0
|
作者：
Gomez-Lumbreras, A. [1 ]
Schmutz, H. [1 ]
Tawfik, A. G. [1 ]
Malone, D. C. [1 ]
机构：
[1] Univ Utah, Coll Pharm, Salt Lake City, UT USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE3
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [21] Comparative effectiveness of metronidazole and vancomycin for treatment of Clostridioides difficile infection in hospitalized children
    Sandora, Thomas J.
    Savage, Timothy J.
    Ryan, Morgan E.
    Dahlberg, Suzanne E.
    Daugherty, Kaitlyn
    Kelly, Ciaran P.
    Pollock, Nira R.
    Kociolek, Larry K.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2025, 5 (01):
  • [22] DECISION ANALYSIS MODEL EVALUATING THE COST-EFFECTIVENESS OF FIDAXOMICIN AND VANCOMYCIN IN THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) FROM A HOSPITAL PERSPECTIVE
    Alowayesh, M. S.
    Holdford, D.
    Harpe, S. E.
    VALUE IN HEALTH, 2012, 15 (04) : A243 - A243
  • [23] Treatment of Clostridioides difficile infection: from guidelines to clinical practice
    Merino, Esperanza
    Salavert, Miguel
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 97 - 101
  • [24] Cost-effectiveness of lipegfilgrastim from the Mexican payer perspective
    Szende, A.
    Bussey, B.
    Szabo, E.
    Klastersky, J.
    Tomey, O.
    Mueller, U.
    Gabriel, S.
    Tang, B.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S117 - S117
  • [25] Clostridioides difficile and Gut Microbiota: From Colonization to Infection and Treatment
    Spigaglia, Patrizia
    PATHOGENS, 2024, 13 (08):
  • [26] COST-EFFECTIVENESS OF OLOROFIM IN INVASIVE ASPERGILLOSIS PATIENTS LACKING SUITABLE ALTERNATIVE TREATMENT OPTIONS FROM A US PAYER PERSPECTIVE
    Walsh, T.
    Bonetti, G.
    Prawitz, T.
    Bresnik, M.
    Coleman, C.
    Lovelace, B.
    VALUE IN HEALTH, 2024, 27 (06) : S98 - S98
  • [27] Synthetic microbial consortia for the treatment of Clostridioides difficile infection in mice model
    Liu, Jinqiu
    Zhu, Wei
    Lessing, Duncan James
    Chu, Weihua
    MICROBIAL BIOTECHNOLOGY, 2023, 16 (10): : 1985 - 2006
  • [28] Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines
    Rajasingham, Radha
    Enns, Eva A.
    Khoruts, Alexander
    Vaughn, Byron P.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (05) : 754 - 762
  • [29] Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection
    Gupta, Sanchit
    Zhu, Jinyi
    McCarty, Thomas R.
    Pruce, Jordan
    Kassam, Zain
    Kelly, Colleen
    Fischer, Monika
    Allegretti, Jessica R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (09) : 2432 - 2440
  • [30] Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection
    Barker, Anna K.
    Scaria, Elizabeth
    Safdar, Nasia
    Alagoz, Oguzhan
    JAMA NETWORK OPEN, 2020, 3 (08)
12345